UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040121
Receipt number R000045747
Scientific Title The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer
Date of disclosure of the study information 2020/04/15
Last modified on 2024/03/20 16:07:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer

Acronym

The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer

Scientific Title

The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer

Scientific Title:Acronym

The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer

Region

Japan


Condition

Condition

Prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

1.The safety for focal high-dose rate brachytherapy using Irisium for clinically localized prostate cancer
2.The efficacy for pathological evaluation of re-biopsy of focal radiation region

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1.The safety for focal high-dose rate brachytherapy using Irisium for clinically localized prostate cancer
2.The efficacy for pathological evaluation of re-biopsy of focal radiation region

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Focal high-dose rate brachytherapy for Prostate using Irisium

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1.Only single region prostate cancer revealed same region, that suspcet of clinically significant cancer by mpMRI prior biopsy
2.Prostate cancer diagnosed pathological examination
3.Proatate cancer of Gleason score 3+3 or 3+4
4.Not ever accepte the therapy for prostate cancer
5.No metastasis region by radiological examination
6.PSA value less than 20ng/ml
7.Performance Status is 0, 1 or2

Key exclusion criteria

1.Prostate cancer region close to rectal wall
2.multiple cancer region diagnosed by prostate biopsy
3.Medical history for radiation therapy of the pelvis
4.Unfit for regularly MRI examination for follow-up
5.Administration of glucocorticoid or 5-arufa reductase
6.Actively double cancer

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Yoshiyuki
Middle name
Last name Miyaji

Organization

Kawasaki Medical School Hospital

Division name

Urology

Zip code

701-0192

Address

577, Matsushima, Kurashiki, Japan

TEL

086-462-1111

Email

miyaji@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Miyaji

Organization

Kawasaki Medical School Hospital

Division name

Urology

Zip code

701-0192

Address

577, Matsushima, Kurashiki, Japan

TEL

086-462-1111

Homepage URL


Email

miyaji@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School Hospita, Department of Urology

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School Hospita, Department of Urology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethics committee of Kawasaki Medical School and Hospital

Address

577, Matsushima, Kurashiki, Japan

Tel

086-462-1111

Email

kmsrec@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 02 Month 08 Day

Date of IRB

2020 Year 04 Month 17 Day

Anticipated trial start date

2020 Year 04 Month 17 Day

Last follow-up date

2024 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 04 Month 09 Day

Last modified on

2024 Year 03 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045747


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name